Evidence map›Paper›PMID 24136296›Full record

Trial reportEuropean journal of immunology2014

Matrix metalloproteinases and tissue damage in HIV-tuberculosis immune reconstitution inflammatory syndrome.

Rebecca Tadokera, Graeme A Meintjes, Katalin A Wilkinson, Keira H Skolimowska, Naomi Walker, Jon S Friedland, Gary Maartens, Paul T G Elkington, Robert J Wilkinson

Open access · hybridAbstract readRandomized Controlled Trial
In one paragraph

Trial report in European journal of immunology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
4.4field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 52 citations in OpenAlex.

  1. Article
  2. Towards host-directed therapy: The role of matrix metalloproteinases in the immunopathogenesis of tuberculosis.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2026
    Review
  3. MedComm · 2023
    Review
  4. Review
  5. Phenotypic Profile ofOpen forum infectious diseases · 2023
    Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. Review
  11. Invariant Natural Killer T-cell Dynamics in Human Immunodeficiency Virus-associated Tuberculosis.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2020
    Article
  12. Article
  13. Review
  14. Observational
  15. Review
  16. Review
  17. Article
  18. Article
  19. Observational
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 2 countries.

Rebecca TadokeraClinical Infectious Diseases Research Initiative, Institute of Infectious Diseases and Molecular Medicine, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.
Graeme A Meintjes
Katalin A Wilkinson
Keira H Skolimowska
Naomi Walker
Jon S Friedland
Gary Maartens
Paul T G Elkington
Robert J Wilkinson
Wellcome Centre for Infectious Diseases Research in Africa · ZAImperial College London · GBUniversity of Cape Town · ZAGF Jooste Hospital · ZAUniversity of Southampton · GB

Funding

Department of Health DHCS/06/05/012Medical Research Council MC_U117588499Medical Research Council U1175.02.002.00014.01Wellcome Trust 081667Wellcome Trust 084323Wellcome Trust 088316
6 · The paper itself

Abstract

The HIV-TB-associated immune reconstitution inflammatory syndrome (TB-IRIS) can complicate combined treatments for HIV-1 and TB. Little is known about tissue damage in TB-IRIS. Matrix metalloproteinases (MMPs) degrade components of the extracellular matrix and consequently may play a role in such immunopathology. Here we investigated the involvement of MMPs in TB-IRIS. We determined MMP transcript abundance and secreted protein in Mycobacterium tuberculosis stimulated PBMCs from 22 TB-IRIS patients and 22 non-IRIS controls. We also measured MMP protein levels in corresponding serum and the effect of prednisone--which reduces the duration of symptoms in IRIS patients--or placebo treatment on MMP transcript and circulating MMP protein levels. PBMCs from TB-IRIS had increased MMP-1, -3, -7, and -10 transcript levels when compared with those of controls at either 6 or 24 h. Similarly, MMP-1, -3, -7, and -10 protein secretion in stimulated cultures was higher in TB-IRIS than in controls. Serum MMP-7 concentration was elevated in TB-IRIS and 2 weeks of corticosteroid therapy decreased this level, although not significantly. TB-IRIS is associated with a distinct pattern of MMP gene and protein activation. Modulation of dysregulated MMP activity may represent a novel therapeutic approach to alleviate TB-IRIS in HIV-TB patients undergoing treatment.

Indexed as

HIV-1AdultAIDS-Related Opportunistic InfectionsAnti-Inflammatory AgentsCells, CulturedCross-Sectional StudiesFemaleGene Expression RegulationHumansImmune Reconstitution Inflammatory SyndromeLeukocytes, MononuclearMaleMatrix MetalloproteinasesMiddle AgedMolecular Targeted TherapyMycobacterium tuberculosisAnti-Inflammatory AgentsMatrix MetalloproteinasesPrednisoneDrug therapy complicationsHIV-1 infectionImmune reconstitution inflammatory syndromeMatrix metalloproteinaseTuberculosis

Identifiers

PMID24136296
PMCPMC3992843
OpenAlexW1508795704

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.